A cohort study of Pemetrexed plus Cisplatin Plus Bevacizumab in patients with previously untreated stage III/IV or non-squamous non-small-cell and lung cancer.
Not Applicable
Recruiting
- Conditions
- on-squamous non-small cell lung cancer
- Registration Number
- JPRN-UMIN000009081
- Lead Sponsor
- ara Medical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patient to the appropriate section of the "contraindication ", "contraindications for coadministration" in the attached document bevacizumab, pemetrexed and cisplatin. 2)Have a serious complications. 3)Patients who participate in the trial is judged to be inappropriate by the attending doctor.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method